The article discusses the role of leukadherins in inflammation treatment. It references the study "Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease," by D. Maiguel and colleagues in the 2011 issue of "Science Signaling." Researcher Vineet Gupta and colleagues showed that leukadherins could inhibit neutrophil recruitment to mice's inflamed peritoneum.